Form 4: Axogen EVP Sells Shares for Tax Obligations

Axogen's EVP & General Counsel, Marc Began, sold 9,278 shares of common stock at a weighted average price of $31.208 to cover tax withholding obligations.

Summary

• Marc A. Began, Executive Vice President & General Counsel of Axogen, Inc. (AXGN), reported a transaction on December 9, 2025.
• The transaction involved the sale of 9,278 shares of Axogen Common Stock.
• The shares were sold at a weighted average price of $31.208 per share.
• This sale was executed to cover tax withholding obligations associated with the vesting of performance stock units on December 4, 2025.
• The filing explicitly states this was not a discretionary trade by Mr. Began.
• Following this transaction, Mr. Began beneficially owns 31,507 shares of Common Stock directly.

Sentiment

Score: 5

Explanation: The transaction reported is a non-discretionary sale of shares by an executive to cover tax withholding obligations related to the vesting of performance stock units. This is a routine event and does not reflect a positive or negative discretionary action by the insider, thus having a neutral sentiment.

Positives

• The vesting of performance stock units, which led to the tax-related sale, indicates that performance targets were met, resulting in the award of shares to the executive.

Future Outlook

The filing does not contain any forward-looking statements or guidance.

Management Comments

• The sale represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of performance stock units on December 4, 2025.
• This sale does not represent a discretionary trade by the Reporting Person.
• The reported price in Column 4 is a weighted average sale price. These shares were sold on December 9, 2025 in multiple transactions at $31.208 per share.

Industry Context

This Form 4 filing reports a routine insider transaction related to executive compensation and tax obligations, which is common across all industries for publicly traded companies. It does not provide specific insights into broader industry trends or competitive landscape for Axogen, Inc.

Comparison to Industry Standards

• This is a standard Form 4 filing for an executive's non-discretionary sale of shares to cover tax obligations upon vesting of equity awards. Such transactions are common practice across publicly traded companies and are not indicative of company-specific performance relative to industry benchmarks. No specific comparable companies, projects, or results are relevant for this type of filing.

Stakeholder Impact

• Shareholders: Minimal direct impact as this is a routine, non-discretionary transaction for tax purposes, not a signal of management's view on the company's future.
• Employees: No direct impact mentioned.
• Customers: No direct impact mentioned.
• Suppliers: No direct impact mentioned.
• Creditors: No direct impact mentioned.

Next Steps

• The Reporting Person undertakes to provide full information regarding the number of shares purchased at each separate price within the reported range upon request to the Issuer, any security holder, or the SEC staff.

Key Dates

Keywords

Axogen, AXGN, Form 4, Insider Transaction, Stock Sale, Executive Compensation, Tax Withholding, Performance Stock Units, Marc Began